| 1 |
Pearce CL, Templeman C, Rossing MA, et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies [J]. Lancet Oncology, 2012,13(4) : 385-394.
|
| 2 |
Gazvani R, Templeton A. New considerations for the pathogenesis of endometriosis [J]. Int J Gynecol Obstet, 2002,76(2): 117-126.
|
| 3 |
Halme J, Hammond MG, Hulka JF. Retrograde menstruation in healthy women and in patients with endometriosis [J]. Obstet Gynecol, 1984, 64, 151-154.
|
| 4 |
Halme J, Hammond MG, Hulka JF, et al. Retrograde menstruation in healthy women and in patients with endometriosis [J]. Obstetrics Gynecology, 1984, 64(2): 151-154.
|
| 5 |
Pearce CL, Templeman C, Rossing MA, et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies [J]. Lancet Oncology, 2012,13(4) : 385-394.
|
| 6 |
Kondi-Pafiti A, Papakonstantinou E, Iavazzo C, et al. Clinicopathological characteristics of ovarian carcinomas associated with endometriosis[J]. Arch Gynecol Obstet, 2012,285(2) : 479-483.
|
| 7 |
Pergialiotis V, Lagkadas A, Polychronis O, et al. Endometriosisassociated ovarian cancer. Presentation of a case report and review of the literature[J]. Eur J,2011,32(6) : 2011,334-337.
|
| 8 |
Boyd J, Sonoda Y, Federici MG, et al. Clinicopathologic features of BRCA-linked and sporadic ovarian cancer [J]. JAMA, 2000, 283(17): 2260-2265.
|
| 9 |
Kobayashi H. Ovarian cancer in endometriosis: Epidemiology, natural history, and clinical diagnosis[J]. Int J Clin Oncol, 2009, 14(5): 378-382.
|
| 10 |
Kato N, Sasou S, Motoyama T. Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary[J]. Mod Pathol, 2005,19(1) : 83-89.
|
| 11 |
Dinulescu DM, Ince TA, Quade BJ, et al. Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer[J]. Nature Med, 2004, 11(1): 63-70.
|
| 12 |
Yamamoto S, Tsuda H, Takano M, et al. Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations[J]. Mod Pathol, 2011,25(4) : 615-624.
|
| 13 |
Wiegand KC, Shah SP, Al-Agha OM, et al. ARID1A mutations in endometriosis-associated ovarian carcinomas [J]. New Eng J Med, 2010, 363(16): 1532-1543.
|
| 14 |
Chou YC, Chen YJ, Lai CR, et al. Cyclooxygenase-2 expression is higher in ovarian cancer tissue adjacent to endometriosis than in ovarian cancer without comorbid endometriosis [J]. Eur J Obstet Gynecol Reprod Biol, 2006,124(1) : 101-105.
|
| 15 |
Keita M, Bessette P, Pelmus M,et al. Expression of interleukin-1 (IL-1) ligands system in the most common endometriosis-associated ovarian cancer subtypes [J]. J Ovarian Res,2010,3 (1): 1757-2215.
|
| 16 |
Hayrabedyan S, Mourdjeva M, Kyurkchiev S, et al. Mmunofluorescent localization of I1-1α,FGF-1,S100A13 as angiogenic factors and a specific ovarian cancer marker (ovac) in endometriosis[J]. Clin Applicat Immunol, 2004,3(1): 310-315.
|
| 17 |
Yamaguchi K, Mandai M, Toyokuni S,et al. Contents of endometriotic cysts,especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the ironinduced persistent oxidative stress[J]. Clin Cancer Res,2008,14 (1): 32-40.
|
| 18 |
Kobayashi H, Ooi H, Yamada Y, et al. Serum CA125 level before the development of ovarian cancer [J]. Int J Gynecol Obstet, 2007,99(2) : 95-99.
|
| 19 |
Tanaka YO, Yoshizako T, Nishida M,et al. Ovarian carcinoma in patients with endometriosis mr imaging findings [J]. Am J Roentgenol, 2000,175(5) : 1423-1430.
|
| 20 |
Sampson JA. Endometrial carcinoma of the ovary, arising in endometrial tissue in that organ[J]. Archiv Surg, 1925,10(1) : 1-2.
|
| 21 |
Scott B. Malignant changes in endometriosis[J]. Obstet Gynecol, 1953,2(3) : 283-289.
|
| 22 |
Lee KR, Nucci MR. Ovarian mucinous and mixed epithelial carcinomas of mullerian (endocervical-like) type : A clinicopathologic analysis of four cases of an uncommon variant associated with endometriosis[J]. Int J Gynecol Pathol,2003,22 (1): 42-51.
|
| 23 |
Satoh T, Hatae M, Watanabe Y,et al. Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: A proposal for patient selection[J]. J Clin Oncol, 2010,28(10) : 1727-1732.
|
| 24 |
Seidman JD, Kurman RJ. Treatment of micropapillary serous ovarian carcinoma (the aggressive variant of serous borderline tumors)[J]. Cancer, 2002,95(4) : 675-676.
|
| 25 |
Prospect of drugs in the treatment of endometriosis[J/CD]. Chin J Obstet Gynecol Pediatr:Electron Ed, 2008,4(3) : 234-238.
|
| 26 |
Kumar S, Munkarah A, Arabi H, et al. Prognostic analysis of ovarian cancer associated with endometriosis [J]. Am J Obstet Gynecol, 2011,204(1) : 63. el-e3,e7.
|
| 27 |
Takano M, Kikuchi Y, Yaegashi N,et al. Clear cell carcinoma of the ovary : A retrospective multicentre experience of 254 patients with complete surgical staging[J]. Br J Cancer, 2006,94(10): 1369-1374.
|